Clinical Trials Browser

Phase 2 × Inflammatory Breast Neoplasms × 2C4 antibody × Clear all

NCT01730833 2025-06-03

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

Phase 2 Active not recruiting

63 enrolled 11 charts

Breast Neoplasms, Inflammatory Breast Neoplasms